Ignite Creation Date:
2024-05-05 @ 5:11 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00403052
Status:
TERMINATED
Last Update Posted:
2019-04-16
First Post:
2006-11-21
Brief Title:
A Study of 1018 Immunostimulatory Sequence ISS Administered With Irinotecan and Cetuximab to Treat Patients With Previously Treated Metastatic Colorectal Cancer
Sponsor:
Dynavax Technologies Corporation
Organization:
Dynavax Technologies Corporation